Institutional investors purchased a net $6.9 million shares of STEM during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 14.80% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRIGATE VENTURES LP Bought 8.3 Million shares of StemCells Inc
SANDERS MORRIS HARRIS LLC (INVES... Sold 10.00 shares of StemCells Inc
METLIFE SECURITIES, INC. Sold 18.00 shares of StemCells Inc